Researchers from New York City-based NYU Langone Health used telephone survey tools to follow up with COVID-19 patients who were hospitalized within the system between March 10, 2020 and May 20, 2020. Of the 790 patients who survived hospitalization in that time, 451 completed a 6-month and/or 12-month follow-up. Of those, 17 percent died between discharge and the one-year follow-up period, and 51 percent reported major life stressors at 12 months.
Multivariable analyses found patients with significant life stressors were twice as likely to experience depression, brain fog, fatigue, sleep issues and other long COVID-19 symptoms.
“Our study is unique in that it explores the impact of life stressors — along with demographic trends and neurologic events — as predictors of long-term cognitive and functional disabilities that affected quality of life in a large population,” said Jennifer Frontera, MD, lead study author and professor of neurology at NYU Langone. “Therapies that lessen the trauma of most stress-inducing life events need to be a central part of treatment for long COVID, with more research needed to validate the best approaches.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
